Idiopathic pulmonary fibrosis (IPF) is a lung condition that scars your lungs and reduces the efficiency of your breathing. It’s the most common type of pulmonary fibrosis. What does IPF

Nuformix plc, a pharmaceutical development company targeting unmet medical needs in fibrosis and oncology via drug repurposing, announce that following the Company’s signing of an exclusive global licensing agreement with

Pharmaceutical company Nuformix said licensing partner Oxilio had progressed the signed a significant service contract with Quotient Sciences. Oxilio had progressed the product NXP001, a proprietary new form of aprepitant